OFFICIAL PUBLICATION OF

by its subsidiary APPco

New Hepatitis C treatment TGA registered

Megan Haggan 06/09/2016

The TGA has registered a new treatment regimen for the treatment of chronic Hepatitis C.MSD announced that Zepatier (elbasvir/grazoprevir) with or without ribavirin has been registered by the TGA for the treatment of chronic hepatitis C virus genotype 1 and 4 infection in adults.The regimen is a once-daily tablet taken for 12 weeks, and is

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Consumer confusion, pharmacist frustration’ if current system continues

The first and foremost role of "expanded scope" is the HMR and collaborative medication management. A clear no brainer which…

Big Pharma

‘I can feel the walls closing in on me as this snowballs’

I'm yet to encounter a corporate provider, Debbie, with the benefits you describe around quality improvement with the corporate business…

Kelly Abbott

‘I can feel the walls closing in on me as this snowballs’

I would argue quality varies in any profession. Most GPs will not refer to a provider where the quality is…

Big Pharma

Wesfarmers targets affordable healthcare

When healthcare is treated as a commodity and patients regarded as consumers, health outcomes are compromised and overall healthcare spending…

Edward Hatfield

New Hepatitis C treatment TGA registered

Previous Medicines: the state of the nation

Next 'Codeine road trips' less likely, but there's still a way to go

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous Medicines: the state of the nation

Next 'Codeine road trips' less likely, but there's still a way to go

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.